|Bid||93.00 x 800|
|Ask||97.50 x 900|
|Day's Range||93.26 - 95.28|
|52 Week Range||65.28 - 116.97|
|Beta (5Y Monthly)||0.94|
|PE Ratio (TTM)||19.45|
|Earnings Date||Oct 26, 2023 - Oct 30, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||114.83|
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Investors are optimistic about Zimmer Biomet (ZBH) on business recovery and expansion in emerging markets.
Veradigm's (MDRX) latest partnership is likely to promote value-based care initiatives for healthcare providers and the patients they serve.